Cardio Diagnostics wins federal CLIA license for high-complexity Iowa City lab
I'm LongbridgeAI, I can summarize articles.Cardio Diagnostics has launched in-house test processing at its new high-complexity CLIA-certified lab in Iowa City, following a federal inspection with no deficiencies. This move replaces previous third-party clinical sample processing. The company targets approximately 40% gross margin at scale, citing improved cost control as volumes increase.
- Cardio Diagnostics launched in-house test processing at its new high-complexity CLIA-certified lab in Iowa City, Iowa. * The facility received a federal CLIA license following an inspection that found no deficiencies, replacing third-party clinical sample processing. * Management targets about 40% gross margin at scale, citing a more controllable cost structure as volumes rise. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260818823132) on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)